Skip to content
Tuesday, November 17, 2026
Explore VIP Palace for the latest in luxury living, travel …

The Zimbabwean Government Declines ‘Unbalanced’ American Health Aid Deal Because of Data Concerns

Health aid image
The proposed US financial assistance was intended for initiatives for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has turned down a significant American healthcare agreement valued at $367m (£272m) over five years over Washington's insistence on confidential biological samples.

This rejection came to light following a internal memorandum from December was leaked, revealing that Head of State Emmerson Mnangagwa believed the agreement was "lopsided".

A government spokesman has since stated that the US was demanding access to biological samples for scientific study and profit while was not willing to guarantee the benefits from any future medical innovations.

"We must now begin the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the United States had donated more than $1.9bn in health funding to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has appealed for continued negotiations to reach a deal acceptable to both sides so the country's vital HIV treatment initiative can be sustained.

Wider Background

This development follows a similar case in Kenya, where a high court suspended a related health funding agreement following concerns were raised about the safety of citizens' medical information.

Since returning to office recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).

The agency had overseen aid for the US government, but Trump argued its spending was "inefficient" and his administration was seeking direct bilateral agreements to boost openness and responsibility.

According to statements, Sixteen African countries have to date signed these new agreements, constituting more than $18.3bn of fresh investment.

Details of the Rejected Agreement

This assistance for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We believe this cooperation would have delivered immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy through US-supported programmes," the Ambassador said.

However, government spokesperson Nick Mangwana said the proposed deal was "unfair".

"The proposal required Zimbabwe to share its genetic material and health information indefinitely, with no corresponding promise of benefiting from any medical innovations – like new medicines or tests – that could be developed from that provided information," his statement read.

"In essence, our nation would supply the raw materials for medical research with no certainty that the resulting innovations would be accessible to our population should a new health crisis arise."

National Interest and Global Health

He also said that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were disrupting frameworks already set up via the global organization.

Mangwana gave as an example its Pandemic Benefit-Sharing system created to deal with future global health emergencies.

"This system is intended to ensure that when a country contributes its samples, the benefits – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."

Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.

"We welcome ongoing discussions with our American counterparts on how subsequent co-operation could be designed in a way that honours the sovereignty and interests of both nations."

Medical Community Reaction

Medical experts said it acknowledged the government's concerns, but recommended that negotiations should continue considering much of the country's HIV programmes depended on external financing.

"Where specific concerns arise, including those involving information security or agreement terms, these can often be addressed via technical clarification and negotiated safeguards," the group commented.

The halted deal highlights the continuing challenges between receiving much-needed international aid and protecting a country's data in an increasingly interconnected world.

About the author

Timothy Riley

A seasoned travel writer and luxury consultant with over a decade of experience exploring the world's most exclusive destinations.

VIP Palace

Type to search articles.